3D Printing Graphite Ink

Hazard statements (CLP)

H315, H319, H336, H351, H360FD, H412

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.

2.2 Label elements

Labelling

Signal word

Danger Danger

Hazard statements

H315 Causes skin irritation. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H360FD May damage fertility. May damage the unborn child. H412 Harmful to aquatic life with long lasting effects. Restricted to professional users. Reduced Labeling (<= 125 ml) H351 Suspected of causing cancer. H412 Harmful to aquatic life with long lasting effects. H360FD May damage fertility. May damage the unborn child.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing mist or vapors. P273 Avoid release to the environment. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

This substance/mixture contains components considered to have endocrine disrupting properties affecting human health, according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.